Survival in Huntington's disease and other young-onset dementias.

Huntington's disease dementia early-onset dementia epidemiology mortality prognosis risk factors survival young-onset dementia

Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
04 2023
Historique:
received: 14 12 2022
accepted: 04 04 2023
medline: 18 4 2023
entrez: 17 4 2023
pubmed: 18 4 2023
Statut: ppublish

Résumé

To compare survival and risk factors associated with mortality in common young-onset dementias (YOD) including Huntington's disease. This retrospective cohort study included inpatients from an Australian specialist neuropsychiatry service, over 20 years. Dementia diagnoses were based on consensus criteria and Huntington's disease (HD) was confirmed genetically. Mortality and cause of death were determined using linkage to the Australian Institute of Health and Welfare National Death Index. There were 386 individuals with YOD included. The dementia types included frontotemporal dementia (FTD) (24.5%), HD (21.2%) and Alzheimer's disease (AD) (20.5%). 63% (n = 243) individuals had died. The longest median survival was for those who had HD, 18.8 years from symptom onset and with a reduced mortality risk compared to AD and FTD (hazard ratio 0.5). Overall, people with YOD had significantly increased mortality, of 5-8 times, compared to the general population. Females with a YOD had higher standardised mortality ratio compared to males (9.3 vs. 4.9) overall. The most frequent cause of death in those with HD was reported as HD, with other causes of death in the other YOD-subtypes related to dementia and mental/behavioural disorders. This is the first Australian study to investigate survival and risk factors of mortality in people with YOD. YOD has a significant risk of death compared to the general population. Our findings provide useful clinical information for people affected by YOD as well as future planning and service provision.

Identifiants

pubmed: 37062919
doi: 10.1002/gps.5913
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e5913

Informations de copyright

© 2023 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

Intern Med J. 2016 Jul;46(7):779-86
pubmed: 27405890
Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):995-1002
pubmed: 17054568
Int Psychogeriatr. 2019 Dec;31(12):1781-1789
pubmed: 30915930
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):15-20
pubmed: 31611263
Int J Geriatr Psychiatry. 2021 Feb;36(2):294-301
pubmed: 32892399
Am J Hum Genet. 2016 Feb 4;98(2):287-98
pubmed: 26849111
Curr Neurol Neurosci Rep. 2011 Oct;11(5):474-83
pubmed: 21861097
Int J Geriatr Psychiatry. 2023 Apr;38(4):e5913
pubmed: 37062919
Dement Geriatr Cogn Disord. 2016;41(1-2):109-22
pubmed: 26854827
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Lancet Neurol. 2020 Feb;19(2):145-156
pubmed: 31810826
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):358-64
pubmed: 22399793
Int Psychogeriatr. 2012 Jul;24(7):1034-45
pubmed: 22325331
Neuron. 2011 Oct 20;72(2):257-68
pubmed: 21944779
J Mov Disord. 2016 Sep;9(3):166-70
pubmed: 27667189
Nature. 1983 Nov 17-23;306(5940):234-8
pubmed: 6316146
Mov Disord Clin Pract. 2017 May 26;4(5):737-742
pubmed: 30363513
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):726-728
pubmed: 30045942
Neurol Sci. 2022 Sep;43(9):5281-5287
pubmed: 35672480
Mov Disord. 2012 Aug;27(9):1083-91
pubmed: 22692795
Dialogues Clin Neurosci. 2016 Dec;18(4):437-446
pubmed: 28179815
Int J Geriatr Psychiatry. 2022 Feb 8;37(3):
pubmed: 35156239
J Neuropsychiatry Clin Neurosci. 2017 Summer;29(3):195-205
pubmed: 28238272
Neurology. 2019 Oct 29;93(18):e1707-e1714
pubmed: 31537715
JAMA Neurol. 2022 Oct 3;:
pubmed: 36190708
J Huntingtons Dis. 2017;6(2):95-103
pubmed: 28671137
Australas Psychiatry. 2022 Feb;30(1):37-40
pubmed: 33626305
J Huntingtons Dis. 2018;7(1):77-86
pubmed: 29480207
Neurol Genet. 2020 Aug 18;6(5):e507
pubmed: 33225064
Aust N Z J Psychiatry. 2022 Jul;56(7):852-861
pubmed: 34420425
Lancet Neurol. 2010 Aug;9(8):793-806
pubmed: 20650401

Auteurs

Samantha M Loi (SM)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.

Paraskevi Tsoukra (P)

Department of Neurology, Evaggelismos Hospital, Athens, Greece.

Emily Sun (E)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Zhibin Chen (Z)

School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.

Pierre Wibawa (P)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Maria di Biase (MD)

Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.

Sarah Farrand (S)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Dhamidhu Eratne (D)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Wendy Kelso (W)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Andrew Evans (A)

Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Mark Walterfang (M)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Dennis Velakoulis (D)

Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH